|
WDR36 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.461400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.192600E-01 |
| Normal-vs-Stage2 |
6.705200E-01 |
| Normal-vs-Stage3 |
5.067400E-01 |
| Normal-vs-Stage4 |
8.417600E-02 |
| Stage1-vs-Stage2 |
7.898000E-01 |
| Stage1-vs-Stage3 |
6.586200E-01 |
| Stage1-vs-Stage4 |
1.559760E-01 |
| Stage2-vs-Stage3 |
9.134800E-01 |
| Stage2-vs-Stage4 |
2.335600E-01 |
| Stage3-vs-Stage4 |
2.307200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.882200E-01 |
| Normal-vs-AfricanAmerican |
8.940000E-01 |
| Normal-vs-Asian |
2.382200E-01 |
| Caucasian-vs-AfricanAmerican |
7.974400E-01 |
| Caucasian-vs-Asian |
6.650400E-01 |
| AfricanAmerican-vs-Asian |
5.522800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.606000E-01 |
| Normal-vs-Female |
2.831600E-02 |
| Male-vs-Female |
1.664480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.801600E-01 |
| Normal-vs-Extreme_Weight |
9.544800E-01 |
| Normal-vs-Obese |
3.220200E-01 |
| Normal-vs-Extreme_Obese |
4.153000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.270400E-01 |
| Normal_Weight-vs-Obese |
5.387600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.265200E-01 |
| Extreme_Weight-vs-Obese |
4.175800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.656600E-01 |
| Obese-vs-Extreme_Obese |
3.210600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.298180E-02 |
| Normal-vs-Age(41-60Yrs) |
2.688300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.607400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.648160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.567600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.304320E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.499800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.161600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.276300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.856600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.764400E-01 |
| Normal-VS-Type2 PRCC |
6.624600E-01 |
| Normal-VS-KIRP CIMP |
2.808100E-02 |
| Normal-VS-Unclassified PRCC |
3.971000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.814200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.718000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.322800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.912300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.751800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.483010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.255200E-01 |
| Normal-vs-N1 |
6.147900E-02 |
| Normal-vs-N2 |
6.321800E-01 |
| N0-vs-N1 |
1.947570E-02 |
| N0-vs-N2 |
5.683400E-01 |
| N1-vs-N2 |
5.781800E-01 |
|
|
